CDNF, Potential DMT for Parkinson’s, May Work as Nasal Spray

CDNF, Potential DMT for Parkinson’s, May Work as Nasal Spray

305878

CDNF, Potential DMT for Parkinson’s, May Work as Nasal Spray

A potential Parkinson’s  therapy based on a protein with an ability to protect neurons — called recombinant (lab-made) human cerebral dopamine neurotrophic factor (rhCDNF) — has been transformed into tiny nanoparticles that may allow for its use as a nasal spray, Herantis Pharma, its developer,  announced. Nanoforming, the process of engineering rhCDNF (also known as CDNF) into nanoparticles, those thousands of times thinner than a human hair, was conducted by Nanoform using its nanoparticle technology. Under a February partnership agreement, Nanoform conducted proof-of-concept studies to determine…

You must be logged in to read/download the full post.